Skip to main content

UPDATE 1-AstraZeneca, Merck eye $1 bln boost from cancer drug success

* Puts drug ahead of competition in PARP medicine race (Adds analyst reaction, sales forecasts)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.